 Home > Active Ingredient News > Antitumor Therapy > Eur Heart J: Incidence, risk factors and death of atrial fibrillation in breast cancer patients

Eur Heart J: Incidence, risk factors and death of atrial fibrillation in breast cancer patients

 Last Update: 2021-12-03
 Source: Internet
 Author: User

Tags

what factors 51

kalanchoe cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

In a multi-ethnic representative cohort of breast cancer patients in the United States , the incidence, prevalence, risk factors, and death outcomes of atrial fibrillation (AF) are not yet clear
.

Recently, the heart blood vessels magazine field authority Eur Heart published a research article on J, the purpose of this study was to evaluate breast cancer patients nationwide AF incidence, risk factors and related mortality

Breast cancer heart blood vessels

Researchers used surveillance, epidemiology, and final results and medical insurance-related databases to identify women over the age of 66 who were newly diagnosed with breast cancer between 2007 and 2014
.

These patients were matched 1:1 with health insurance participants who did not have cancer, and each pair was followed up for 1 year to determine the main outcome of AF

diagnosis

The researchers calculated the cumulative incidence using competitive risk survival statistics
.

After that, the researchers used the adjusted Cox proportional hazards model to determine the risk factors for AF in breast cancer patients

The study included 85,423 breast cancer patients, of which 9,425 (11.
0%) had been diagnosed with AF before breast cancer was diagnosed
.

Within 1 year after breast cancer diagnosis, 2993 (3.

It can be seen that the incidence of AF is significantly higher in women after the diagnosis of breast cancer
.

A higher breast cancer stage at diagnosis is significantly associated with a higher risk of AF

After women diagnosed with breast cancer, the incidence of AF is significantly higher

Original source:

Avirup Guha.

Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-Medicare analysis in this message

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.